Overview Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia Status: Completed Trial end date: 2006-09-01 Target enrollment: Participant gender: Summary The aim of this study is to demonstrate the effectiveness and safety of 500 units of Dysport manufactured at a new manufacturing facility in Europe. Phase: Phase 3 Details Lead Sponsor: IpsenTreatments: abobotulinumtoxinABotulinum ToxinsBotulinum Toxins, Type AincobotulinumtoxinAonabotulinumtoxinA